Inhaled H057 for worsening bronchiectasis symptoms
Part of Lungs & breathing clinical trials.
This trial tests an inhaled medicine called H057 for people whose bronchiectasis symptoms (like cough, more phlegm, or shortness of breath) have suddenly gotten worse. The goal is to see if it can help control this worsening episode.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your bronchiectasis symptoms (like cough, thicker phlegm, or trouble breathing) must have been worse than usual for more than 2 days, and your doctor says you need treatment.
- You must be able to use a nebulizer (a machine that turns liquid medicine into mist you breathe in).
- You must understand the trial and agree to take part by signing a form.
- You cannot have bronchiectasis caused by cystic fibrosis, active tuberculosis, or certain other lung infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, HSK31858, for people with non-cystic fibrosis bronchiectasis (a lung condition causing chronic cough and infections). It aims to see if the drug reduces lung flare-ups and improves symptoms.
This study tests whether an investigational tablet called XH-S004 can reduce flare-ups and improve symptoms in people with bronchiectasis (widened airways that trap mucus). It is for adults who produce phlegm daily and have had at least two worsening episodes in the last year.
This trial tests an inhaled medication for people with bronchiectasis, a lung condition causing chronic cough and mucus. It first checks safety in healthy volunteers, then studies how the drug works in people with bronchiectasis.
This study tests how safe an experimental inhaled medicine (HSK31858) is for people with non-cystic fibrosis bronchiectasis, a lung condition where airways are damaged and collect mucus. You can only join if you already completed a previous HSK31858 study.
This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.
This study tests a new medicine for people with non-cystic fibrosis bronchiectasis. It aims to see if the drug can help reduce symptoms and improve quality of life.
Hear when a new Acute Exacerbations of Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.